Abstract
The potential use of genetic vaccines to address numerous diseases including cancer is promising, but currently unrealized. Here, we review advances in the nonviral delivery of antigen-encoded plasmid DNA for the purpose of treating cancer through the human immune system, as this disease has drawn the most attention in this field to date. Brief overviews of dendritic cell immunobiology and the mechanism of immune activation through genetic vaccines set the stage for the desirability of delivery technology. Several promising nonviral delivery techniques are discussed along with a mention of targeting strategies aimed at improving the potency of vaccine formulations. Implications for the future of genetic vaccines are also presented.
Preview
Unable to display preview. Download preview PDF.
References
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G et al. (1990) Science 247:1465–1468
Tang DC, De Vit M, Johnston SA (1992) Nature 356:152–154
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL et al. (1993) Science 259:1745–1749
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC et al. (1993) P Natl Acad Sci USA 90:11478–11482
Johnston SA, Barry MA (1997) Vaccine 15:808–809
Chambers RS, Johnston SA (2003) Nat Biotechnol 21:1088–1092
Banchereau J, Steinman RM (1998) Nature 392:245–252
Bousso P, Robey E (2003) Nat Immunol 4:579–585
Dallal RM, Lotze MT (2000) Curr Opin Immunol 12:583–588
Wolff JA, Dowty ME, Jiao S, Repetto G, Berg RK et al. (1992) J Cell Sci 103:1249–1259
Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R et al. (1994) Transplantation 57:990–996
Nickoloff BJ, Turka LA (1994) Immunol Today 15:464–469
Warrens AN, Zhang JY, Sidhu S, Watt DJ, Lombardi G et al. (1994) Int Immunol 6:847–853
Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M et al. (1995) Science 268:1343–1347
Corr M, Lee DJ, Carson DA, Tighe H (1996) J Exp Med 184:1555–1560
Ulmer JB, Deck RR, Dewitt CM, Donnhly JI, Liu MA (1996) Immunology 89:59–67
Doe B, Selby M, Barnett S, Baenziger J, Walker CM (1996) P Natl Acad Sci USA 93:8578–8583
Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH (1997) J Immunol 159:11–14
Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr (1996) Nat Med 2:1122–1128
Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA (1997) J Exp Med 186:1481–1486
Chattergoon MA, Robinson TM, Boyer JD, Weiner DB (1998) J Immunol 160:5707–5718
Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP et al. (1998) J Exp Med 188:1075–1082
La Cava A, Billetta R, Gaietta G, Bonnin DB, Baird SM et al. (2000) J Immunol 164:1340–1345
Chun S, Daheshia M, Lee S, Eo SK, Rouse BT (1999) J Immunol 163:2393–2402
Timares L, Takashima A, Johnston SA (1998) P Natl Acad Sci USA 95:13147–13152
Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL (1995) Nat Med 1:649–653
Kovacsovics-Bankowski M, Rock KL (1995) Science 267:243–246
Suto R, Srivastava PK (1995) Science 269:1585–1588
Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR (1997) J Exp Med 186:65–70
Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR (1997) J Exp Med 186:239–245
Coelho-Castelo AA, Santos Junior RR, Bonato VL, Jamur MC, Oliver C et al. (2003) Hum Gene Ther 14:1279–1285
Pardoll D (2003) Annu Rev Immunol 21:807–839
Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Adv Immunol 74:181–273
Houghton AN (1994) J Exp Med 180:1–4
Pardoll DM (2002) Nat Rev Immunol 2:227–238
Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM et al. (2000) Science 290:486–492
Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M et al. (2000) Vaccine 18:1893–1901
Felgner PL (2003) Methods 31:181–182
Manthorpe M, Cornefert-Jensen F, Hartikka J, Felgner J, Rundell A et al. (1993) Hum Gene Ther 4:419–431
Winegar RA, Monforte JA, Suing KD, O'Loughlin KG, Rudd CJ et al. (1996) Hum Gene Ther 7:2185–2194
Jiao S, Williams P, Berg RK, Hodgeman BA, Liu L et al. (1992) Hum Gene Ther 3:21–33
Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG et al. (1991) P Natl Acad Sci USA 88:2726–2730
Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH et al. (1995) Vaccine 13:1427–1430
Bergstresser PR, Fletcher CR, Streilein JW (1980) J Invest Dermatol 74:77–80
Tuettenberg A, Jonuleit H, Tuting T, Bruck J, Knop J et al. (2003) Gene Ther 10:243–250
Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA (2003) Curr Opin Mol Ther 5:10–19
Vicat JM, Boisseau S, Jourdes P, Laine M, Wion D et al. (2000) Hum Gene Ther 11:909–916
Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M et al. (2001) Cancer Res 61:859–863
Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X et al. (2001) Cancer Res 61:3281–4
Kalat M, Kupcu Z, Schuller S, Zalusky D, Zehetner M et al. (2002) Cancer Res 62:5489–5494
Paster W, Zehetner M, Kalat M, Schuller S, Schweighoffer T (2003) Gene Ther 10:717–724
Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D et al. (2002) Vaccine 20:3399–3408
Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E (2001) Arch Med Res 32:273–276
Zabner J (1997) Adv Drug Deliver Rev 27:17–28
Xu Y, Szoka FC Jr (1996) Biochemistry 35:5616–5623
Gregoriadis G, Saffie R, de Souza JB (1997) FEBS Lett 402:107–110
Perrie Y, Frederik PM, Gregoriadis G (2001) Vaccine 19:3301–3310
Perrie Y, Obrenovic M, McCarthy D, Gregoriadis G (2002) J Lipos Res 12:185–197
Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD et al. (1997) Gene Ther 4:969–976
Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D (1999) Gene Ther 6:1768–1773
Tanaka M, Kaneda Y, Fujii S, Yamano T, Hashimoto K et al. (2002) Mol Ther 5:291–299
Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D et al. (2001) Eur J Cancer 37:2097–2103
Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH (1997) Vaccine 15:814–817
Kempf M, Mandal B, Jilek S, Thiele L, Voros J et al. (2003) J Drug Target 11:11–18
O'Hagan DT, Singh M, Gupta RK (1998) Adv Drug Deliver Rev 32:225–246
Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Immunity 11:753–761
Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle HP et al. (2001) J Control Release 76:59–71
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S et al. (2000) Nature 408:740–745
Frazza EJ, Schmitt EE (1971) J Biomed Mater Res 5:43–58
Woodland JH, Yolles S (1973) J Med Chem 16:897–901
Beck LR, Cowsar DR, Lewis DH, Gibson JW, Flowers CE (1979) Am J Obstet Gynecol 135:419–426
Sinclair RG (1973) Environ Sci Technol 7:955–956
Rokkanen P, Bostman O, Vainionpaa S, Vihtonen K, Tormala P et al. (1985) Lancet 1:1422–1424
Bercovy M, Goutallier D, Voisin MC, Geiger D, Blanquaert D et al. (1985) Clin Orthop Relat R 196:159–168
Williams DF, Mort E (1977) J Bioeng 1:231–238
Langer R, Cleland JL, Hanes J (1997) Adv Drug Deliver Rev 28:97–119
Odonnell PB, McGinity JW (1997) Adv Drug Deliver Rev 28:25–42
Gander B, Wehrli E, Alder R, Merkle HP (1995) J Microencapsul 12:83–97
Wang D, Robinson DR, Kwon GS, Samuel J (1999) J Control Release 57:9–18
Walter E, Moelling K, Pavlovic J, Merkle HP (1999) J Control Release 61:361–374
Hedley ML, Curley J, Urban R (1998) Nat Med 4:365–368
Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML et al. (2002) Clin Cancer Res 8:1028–1037
Sheets EE, Urban RG, Crum CP, Hedley ML, Politch JA et al. (2003) Am J Obstet Gynecol 188:916–926
Chen SC, Jones DH, Fynan EF, Farrar GH, Clegg JC et al. (1998) J Virol 72:5757–5761
Fu K, Pack DW, Klibanov AM, Langer R (2000) Pharmaceut Res 17:100–106
Shenderova A, Burke TG, Schwendeman SP (1999) Pharmaceut Res 16:241–248
Walter E, Dreher D, Kok M, Thiele L, Kiama SG et al. (2001) J Control Release 76:149–168
Garg S, Oran A, Wajchman J, Sasaki S, Maris CH et al. (2003) Nat Immunol 4:907–912
McKeever U, Barman S, Hao T, Chambers P, Song S et al. (2002) Vaccine 20:1524–1531
Ando S, Putnam D, Pack DW, Langer R (1999) J Pharm Sci 88:126–130
Singh M, Briones M, Ott G, O'Hagan D (2000) P Natl Acad Sci USA 97:811–816
Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B et al. (2000) Gene Ther 7:2105–2112
Denis-Mize KS, Dupuis M, Singh M, Woo C, Ugozzoli M et al. (2003) Cell Immunol 225:12–20
O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S et al. (2001) J Virol 75:9037–9043
Luo YP, O'Hagan D, Zhou H, Singh M, Ulmer J et al. (2003) Vaccine 21:1938–1947
Cui Z, Mumper RJ (2002) Bioconjug Chem 13:1319–1327
Cui Z, Mumper RJ (2002) J Control Release 81:173–184
Cui Z, Mumper RJ (2002) Pharmaceut Res 19:939–946
Cui Z, Mumper RJ (2002) J Pharm Pharmacol 54:1195–1203
Cui Z, Baizer L, Mumper RJ (2003) J Biotechnol 102:105–115
Kumar M (2000) React Funct Polym 46:1–27
Stahl PD (1992) Curr Opin Immunol 4:49–52
Roy K, Mao HQ, Huang SK, Leong KW (1999) Nat Med 5:387–391
Cui Z, Mumper RJ (2001) J Control Release 75:409–419
Kabbaj M, Phillips NC (2001) J Drug Target 9:317–328
Wang C, Ge Q, Ting D, Nguyen D, Shen HR et al. (2004) Nat Mater 3:190–196
Little SR, Lynn DM, Ge Q, Anderson DG, Puram SV et al. (2004) P Natl Acad Sci USA 101:9534–9539
Lynn DM, Anderson DG, Putnam D, Langer R (2001) J Am Chem Soc 123:8155–8156
Lynn DM, Amiji MM, Langer R (2001) Angew Chem Int Edit 40:1707–1710
Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D et al. (1995) P Natl Acad Sci USA 92:7297–7301
Fields RC, Shimizu K, Mule JJ (1998) P Natl Acad Sci USA 95:9482–9487
Alters SE, Gadea JR, Sorich M, O'Donoghue G, Talib S et al. (1998) J Immunother 21:17–26
Tjandrawan T, Martin DM, Maeurer MJ, Castelli C, Lotze MT et al. (1998) J Immunother 21:149–157
Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr (1996) J Exp Med 183:283–287
Amoscato AA, Prenovitz DA, Lotze MT (1998) J Immunol 161:4023–4032
Gong J, Chen D, Kashiwaba M, Kufe D (1997) Nat Med 3:558–561
Siders WM, Vergilis KL, Johnson C, Shields J, Kaplan JM (2003) Mol Ther 7:498–505
Diebold SS, Lehrmann H, Kursa M, Wagner E, Cotten M et al. (1999) Hum Gene Ther 10:775–786
Irvine AS, Trinder PK, Laughton DL, Ketteringham H, McDermott RH et al. (2000) Nat Biotechnol 18:1273–1278
Walter E, Merkle HP (2002) J Drug Target 10:11–21
Walter E, Thiele L, Merkle HP (2001) STP Pharma Sci 11:45–56
Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM et al. (1997) Cancer Gene Ther 4:17–25
Chamarthy SP, Kovacs JR, McClelland E, Gattens D, Meng WS (2003) Mol Immunol 40:483–490
Strobel I, Berchtold S, Gotze A, Schulze U, Schuler G et al. (2000) Gene Ther 7:2028–2035
Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E (2000) Cancer Res 60:1028–1034
Milazzo C, Reichardt VL, Muller MR, Grunebach F, Brossart P (2003) Blood 101:977–982
Muller MR, Grunebach F, Nencioni A, Brossart P (2003) J Immunol 170:5892–5896
Nencioni A, Muller MR, Grunebach F, Garuti A, Mingari MC et al. (2003) Cancer Gene Ther 10:209–214
Heiser A, Maurice MA, Yancey DR, Coleman DM, Dahm P et al. (2001) Cancer Res 61:3388–3393
Su Z, Dannull J, Heiser A, Yancey D, Pruitt S et al. (2003) Cancer Res 63:2127–2133
Muller MR, Tsakou G, Grunebach F, Schmidt SM, Brossart P (2004) Blood 103:1763–1769
Zhao Y, Boczkowski D, Nair SK, Gilboa E (2003) Blood 102:4137–4142
Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C et al. (1999) J Exp Med 189:371–380
Kim JJ, Yang JS, Dang K, Manson KH, Weiner DB (2001) Clin Cancer Res 7:882s–889s
Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW (1999) Nat Biotechnol 17:253–258
Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P et al. (1998) J Exp Med 188:1359–1368
Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A et al. (1995) Nature 375:151–155
Cui Z, Hsu CH, Mumper RJ (2003) Drug Dev Ind Pharm 29:689–700
Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL (2001) J Virol 75:10421–10430
Rodriguez F, An LL, Harkins S, Zhang J, Yokoyama M et al. (1998) J Virol 72:5174–5181
Rodriguez F, Zhang J, Whitton JL (1997) J Virol 71:8497–8503
Delogu G, Howard A, Collins FM, Morris SL (2000) Infect Immun 68:3097–3102
Tobery T, Siliciano RF (1999) J Immunol 162:639–642
Fu TM, Guan L, Friedman A, Ulmer JB, Liu MA et al. (1998) Vaccine 16:p1711–1717
Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P (1996) Immunity 5:103–114
Spee P, Neefjes J (1997) Eur J Immunol 27:2441–2449
Pike SE, Yao L, Jones KD, Cherney B, Appella E et al. (1998) J Exp Med 188:2349–2356
Pike SE, Yao L, Setsuda J, Jones KD, Cherney B et al. (1999) Blood 94:2461–2468
Cheng WF, Hung CF, Chai CY, Hsu KF, He L et al. (2001) J Clin Invest 108:669–678
Rowell JF, Ruff AL, Guarnieri FG, Staveley-O'Carroll K, Lin X et al. (1995) J Immunol 155:1818–1828
Ji H, Wang TL, Chen CH, Pai SI, Hung CF et al. (1999) Hum Gene Ther 10:2727–2740
Wu TC, Guarnieri FG, Staveley-O'Carroll KF, Viscidi RP, Levitsky HI et al. (1995) P Natl Acad Sci USA 92:11671–11675
Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL (2001) J Virol 75:10421–10430
Forns X, Emerson SU, Tobin GJ, Mushahwar IK, Purcell RH et al. (1999) Vaccine 17:1992–2002
Geissler M, Bruss V, Michalak S, Hockenjos B, Ortmann D et al. (1999) J Virol 73:4284–4292
Rice J, King CA, Spellerberg MB, Fairweather N, Stevenson FK (1999) Vaccine 17:3030–3038
Steinman RM, Hawiger D, Nussenzweig MC (2003) Annu Rev Immunol 21:685–711
Morita A, Ariizumi K, Ritter R 3rd, Jester JV, Kumamoto T et al. (2001) Gene Ther 8:1729–1737
Ross R, Sudowe S, Beisner J, Ross XL, Ludwig-Portugall I et al. (2003) Gene Ther 10:1035–1040
Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB (2003) Mol Ther 8:567–575
Schlesinger S, Dubensky TW (1999) Curr Opin Biotechnol 10:434–439
Wang B, Merva M, Dang K, Ugen KE, Boyer J et al. (1994) AIDS Res Hum Retrov 10:S35–41
Little SR, Lynn DM, Puram SV, Langer R (2005) J Con Rel 107(3):449–462
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Little, S.R., Langer, R. Nonviral Delivery of Cancer Genetic Vaccines. In: Schaffer, D.V., Zhou, W. (eds) Gene Therapy and Gene Delivery Systems. Advances in Biochemical Engineering/Biotechnology, vol 99. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_004
Download citation
DOI: https://doi.org/10.1007/10_004
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28404-8
Online ISBN: 978-3-540-32412-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)